Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
for Adenoid Cystic Carcinoma
8 locations incl. Boston
Sponsor: Rgenta Therapeutics Inc
Sex: All·Age: 18+
Code: NCT06462183·Phase 1·Recruiting